Telehealth Mastery Short Course —Combining genetic and clinical risk models for better, proactive breast health
Telehealth Mastery Short Course — Combining genetic and clinical risk models for better proactive breast health
The GP is the gateway to preventative care. By enabling the GP to risk stratify their patient population with the most clinically applicable risk assessment models available, they will have greater insight to their patients’ risk of developing disease and therefore will be able to provide better screening and prevention recommendations to the patient. In the context of breast cancer risk assessment, our aim is to build on traditional family history assessment to show why it is as important to assess women that do not have the family history risk of disease.
Telehealth Mastery Short Course — Relevance to General Practice
As the field of medicine continues to evolve, preventative care is not only becoming more of a reality, but is a way for clinicians to differentiate themselves.
Advances in genetic technologies and large-scale consortia studies over the past decade have enabled clinical risk prediction improvements beyond traditional means.
This course will highlight the advancements in clinical risk assessment models and the benefit risk assessment can add to your practice. Any risk assessment is better than none; we will walk through the benefits of identifying breast cancer family history and elaborate on the multifactorial nature of breast cancer to emphasize the importance of a more robust risk assessment. The National Breast Cancer Foundation’s mission of zero breast cancer deaths by 2030 has to start at the GP level.
By assessing risk in your patient population you increase awareness, identify at-risk women and can optimize screening and prevention plans for your patient population.
Learning Outcomes for Telehealth Mastery Short Course – How to be more proactive in the breast health of your patients: genetic testing for breast cancer
- Describe the basic differences between sporadic breast cancer and hereditary/familial breast cancer and identify the major risk factors that are associated with sporadic breast cancer development.
- Identify the utility of clinically available risk assessment models that help clinicians assess the risk of their patients—particularly in those that are not covered in RACGP guidelines (ie-have no family history)
- Discuss the available prevention and screening options to the women identified as at-increased-risk of developing breast cancer.
- Identify how to drive awareness and compliance and offer precise strategies for achieving better outcomes for your patients with regard to Breast Cancer screening.
- Outline the process of integrating this testing with your patients through Telehealth.
Telehealth Mastery Short Course — Combining genetic and clinical risk models for better proactive breast health
SPECIAL COURSE PRICE:
The course is being offered for FREE till late November 2021.
BONUS: The first 150 general practitioners to register for the course will be sent three complimentary breast screening tests to use for your patients (valued at $1,050).
Course Enrolment Dates
Telehealth Mastery Short Course — Combining genetic and clinical risk models for better, proactive breast health is a virtual course offered throughout 2021.
Once you enrol, you have 6 weeks to complete the course.
